https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46895 Wed 24 May 2023 12:48:58 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42242 90% of patients exhibiting concentrations within the defined target range throughout the entire treatment course. Additional work to formally establish target therapeutic concentrations is required; however, this study provides a valuable first step in determining optimal ribavirin treatment regimens for paramyxovirus infections in the lung transplant population.]]> Fri 19 Aug 2022 11:56:24 AEST ]]>